Histopathologic Effect of Calcium Electroporation on Cancer in the Skin
NCT04259658 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2023-10-03
Summary
In this phase II study we investigate the effect of calcium electroporation on cancer in the skin investigated by histopathology.
Conditions
Interventions
- COMBINATION_PRODUCT
-
Calcium electroporation
Patients with cutaneous metastases will be treated with calcium electroporation.
Sponsors & Collaborators
-
Zealand University Hospital
lead OTHER
Principal Investigators
-
Julie Gehl, MD · Zealand University Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-20
- Primary Completion
- 2022-10-19
- Completion
- 2023-07-27
Countries
- Denmark
Study Locations
More Related Trials
-
Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
NCT01528956 ·Status: COMPLETED
-
Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery
NCT02583269 ·Status: COMPLETED ·Phase: PHASE1
-
Epigenetic Changes in Head and Neck Cancer
NCT04260074 ·Status: COMPLETED
-
Study of DNA in Blood Samples From Patients With Neuroblastoma
NCT00898391 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma
NCT01510600 ·Status: COMPLETED
-
Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882
NCT00898469 ·Status: COMPLETED
-
Biomarkers in Samples From Young Patients With Neuroblastoma
NCT01358604 ·Status: COMPLETED
-
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
NCT00899132 ·Status: TERMINATED
-
Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma
NCT01374672 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy
NCT00898430 ·Status: TERMINATED
-
Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871
NCT01015963 ·Status: COMPLETED
-
Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
NCT00318604 ·Status: UNKNOWN
-
Development and Validation of a New Digital Dermatoscope in the United States
NCT04047316 ·Status: COMPLETED
-
Collection of Tissue Blocks or Slides From Patients With Cancer
NCT02810405 ·Status: COMPLETED
-
Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma
NCT01062438 ·Status: COMPLETED
-
Prediction of Getting Peripheral Neuropathy in Patients Treated With Bortezomib?
NCT05781425 ·Status: COMPLETED
-
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
NCT00991991 ·Status: TERMINATED
-
Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells
NCT00020072 ·Status: COMPLETED ·Phase: NA
-
Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
NCT01642095 ·Status: WITHDRAWN
-
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
NCT00043615 ·Status: COMPLETED
-
Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
NCT01198171 ·Status: COMPLETED
-
Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder
NCT01511575 ·Status: COMPLETED
-
Microscopy Imaging of Whole-mount Stained Human Tissues
NCT05689112 ·Status: RECRUITING
-
DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer
NCT00898664 ·Status: COMPLETED
-
Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas
NCT01802125 ·Status: COMPLETED